My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 194

    1.

    Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial.

    McCarron DA, Morris CD.

    Ann Intern Med. 1985 Dec;103(6 ( Pt 1)):825-31.PMID: 3904559 [PubMed - indexed for MEDLINE]Related articles

    2.

    Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.

    Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG.

    BMJ. 1989 Jan 28;298(6668):227-30.PMID: 2493869 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.

    McGill JB, Reilly PA.

    Clin Ther. 2001 Jun;23(6):833-50.PMID: 11440284 [PubMed - indexed for MEDLINE]Related articles

    4.

    Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.

    Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP.

    Circulation. 2005 Mar 1;111(8):1012-8. Epub 2005 Feb 21.PMID: 15723979 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.

    Pathak L, Hiremath, Kerkar PG, Manade VG.

    J Assoc Physicians India. 2004 Mar;52:197-202.PMID: 15636308 [PubMed - indexed for MEDLINE]Related articles

    6.

    Monotherapy with felodipine, a new calcium antagonist, in mild and moderate hypertension.

    Hamilton DV, Barnes PC, Bowles RM, Rajaratnam DV, Comerford MB, Ginks WR, Ginks SE, Goves JR, Grabau WJ, Malcolm JP, et al.

    J Cardiovasc Pharmacol. 1987;10 Suppl 10:S111-3.PMID: 2455107 [PubMed - indexed for MEDLINE]Related articles

    7.

    Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.

    Verdecchia P, Brignole M, Delfino G, Queirolo C, De Marchi G, Bertulla A.

    Hypertension. 1983 Jan-Feb;5(1):140-6.PMID: 6336719 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Controlled trial of long-term oral calcium supplementation in essential hypertension.

    Strazzullo P, Siani A, Gugliemi S, Di Carlo A, Galletti F, Cirillo M, Mancini M.

    Hypertension. 1986 Nov;8(11):1084-8.PMID: 3770869 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.

    Frishman WH, Klein NA, Klein P, Strom JA, Tawil R, Strair R, Wong B, Roth S, LeJemtel TH, Pollack S, Sonnenblick EH.

    Am J Cardiol. 1982 Nov;50(5):1164-72.PMID: 6127946 [PubMed - indexed for MEDLINE]Related articles

    10.

    Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.

    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS; Korean Multicenter Amlodipine Study Investigators.

    Clin Ther. 2007 Sep;29(9):1924-36.PMID: 18035192 [PubMed - indexed for MEDLINE]Related articles

    11.

    Does oral calcium supplementation lower high blood pressure? A double blind study.

    Cappuccio FP, Markandu ND, Singer DR, Smith SJ, Shore AC, MacGregor GA.

    J Hypertens. 1987 Feb;5(1):67-71.PMID: 3295037 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.

    Winer N, Thys-Jacobs S, Kumar R, Davidson WD, Grayson M, Harris C, Walker D, Itskovitz H, Gonasun L.

    Clin Pharmacol Ther. 1987 Oct;42(4):442-8.PMID: 2959426 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.

    Frishman WH, Charlap S, Goldberger J, Kimmel B, Stroh J, Dorsa F, Allen L, Strom J.

    Am J Cardiol. 1985 Dec 6;56(16):41H-46H.PMID: 3934948 [PubMed - indexed for MEDLINE]Related articles

    14.

    Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men.

    Kirby RS.

    Urology. 1995 Aug;46(2):182-6.PMID: 7542819 [PubMed - indexed for MEDLINE]Related articles

    15.

    Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.

    Webb DJ, Freestone S, Allen MJ, Muirhead GJ.

    Am J Cardiol. 1999 Mar 4;83(5A):21C-28C.PMID: 10078539 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.

    Mistry GC, Maes AL, Lasseter KC, Davies MJ, Gottesdiener KM, Wagner JA, Herman GA.

    J Clin Pharmacol. 2008 May;48(5):592-8. Epub 2008 Mar 19.PMID: 18353996 [PubMed - indexed for MEDLINE]Related articles

    17.

    The inconsistent effects of calcium supplements upon blood pressure in primary hypertension.

    Meese RB, Gonzales DG, Casparian JM, Ram CV, Pak CM, Kaplan NM.

    Am J Med Sci. 1987 Oct;294(4):219-24.PMID: 3310639 [PubMed - indexed for MEDLINE]Related articles

    18.

    Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.

    Davidov ME, Moir GD, Poland MP, Maloy J, Medakovic M.

    Am J Med. 1983 Oct 17;75(4A):47-53.PMID: 6356899 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.

    J Hum Hypertens. 2002 Jan;16(1):13-9.PMID: 11840225 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Step II treatment with labetalol for essential hypertension.

    Bloomfield SS, Lucas CP, Gantt CL, Poland MP, Medakovic M.

    Am J Med. 1983 Oct 17;75(4A):81-6.PMID: 6356902 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity